Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)May 31, 2025 | (FY)Feb 28, 2025 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 25.68%34.31B | 23.58%116.06B | 21.76%26.8B | 25.69%27.3B | 23.42%93.91B | 26.19B | 20.36%23.99B | 25.85%22.01B | 24.05%21.72B | 32.00%76.09B |
| Cost of revenue | 19.03%15.09B | 25.70%53.6B | 30.24%13.59B | 29.65%12.67B | 26.65%42.64B | 11.53B | 26.05%10.91B | 26.20%10.43B | 22.25%9.78B | 24.38%33.67B |
| Gross profit | 31.44%19.22B | 21.83%62.46B | 14.12%13.21B | 22.45%14.62B | 20.85%51.27B | 14.66B | 16.00%13.09B | 25.53%11.58B | 25.57%11.94B | 38.75%42.42B |
| Operating expense | 35.71%7.02B | 16.38%19.84B | 11.07%4.54B | 31.29%5.17B | 36.32%17.05B | 4.64B | 47.08%4.39B | 29.94%4.08B | 31.89%3.94B | 38.10%12.51B |
| Selling and administrative expenses | 35.73%7.02B | 16.41%19.85B | 11.06%4.54B | 31.32%5.17B | 36.32%17.05B | --4.64B | 47.08%4.39B | 29.97%4.09B | 31.89%3.94B | 38.08%12.51B |
| -General and administrative expense | 35.73%7.02B | 16.41%19.85B | 11.06%4.54B | 31.32%5.17B | 36.32%17.05B | --4.64B | 47.08%4.39B | 29.97%4.09B | 31.89%3.94B | 38.08%12.51B |
| Total other operating income | 100.00%2M | 400.00%5M | 0.00%1M | --1M | 0.00%1M | --0 | ---- | --1M | --0 | -50.00%1M |
| Operating profit | 29.11%12.21B | 24.54%42.62B | 15.78%8.67B | 18.10%9.46B | 14.38%34.22B | 10.03B | 4.82%8.7B | 23.24%7.49B | 22.68%8.01B | 39.03%29.92B |
| Net non-operating interest income (expenses) | 10.53%-17M | -16.95%-69M | -40.00%-21M | -137.50%-19M | -43.90%-59M | -18M | -80.00%-18M | -36.36%-15M | 27.27%-8M | 16.33%-41M |
| Non-operating interest expense | -10.53%17M | 16.95%69M | 40.00%21M | 137.50%19M | 43.90%59M | --18M | 80.00%18M | 36.36%15M | -27.27%8M | -16.33%41M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 29.19%12.19B | 24.55%42.55B | 15.73%8.65B | 17.98%9.44B | 14.34%34.16B | 10.01B | 4.73%8.68B | 23.22%7.48B | 22.76%8B | 39.15%29.88B |
| Income tax | 28.87%3.17B | 34.27%11.79B | 11.23%2.26B | 13.45%2.46B | 10.21%8.78B | 2.22B | -1.83%2.36B | 15.47%2.03B | 14.99%2.17B | 34.43%7.97B |
| Net income | 29.30%9.02B | 21.19%30.76B | 17.40%6.4B | 19.67%6.97B | 15.85%25.38B | 7.79B | 7.41%6.32B | 26.38%5.45B | 25.93%5.83B | 40.95%21.91B |
| Net income continuous operations | 29.30%9.02B | 21.19%30.76B | 17.40%6.4B | 19.67%6.97B | 15.85%25.38B | --7.79B | 7.41%6.32B | 26.38%5.45B | 25.93%5.83B | 40.95%21.91B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 29.30%9.02B | 21.19%30.76B | 17.40%6.4B | 19.67%6.97B | 15.85%25.38B | 7.79B | 7.41%6.32B | 26.38%5.45B | 25.93%5.83B | 40.95%21.91B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 29.30%9.02B | 21.19%30.76B | 17.40%6.4B | 19.67%6.97B | 15.85%25.38B | 7.79B | 7.41%6.32B | 26.38%5.45B | 25.93%5.83B | 40.95%21.91B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 29.77%59.32 | 21.75%202.16 | 18.03%42.09 | 20.13%45.71 | 16.14%166.04 | 50.95 | 7.73%41.38 | 26.72%35.66 | 26.16%38.05 | 41.00%142.96 |
| Diluted earnings per share | 29.77%59.32 | 21.75%202.16 | 18.03%42.09 | 20.13%45.71 | 16.14%166.04 | 50.95 | 7.73%41.38 | 26.72%35.66 | 26.16%38.05 | 41.38%142.96 |
| Dividend per share | 0 | 44.19%62 | 38.89%25 | 0 | 16.22%43 | 25 | 0 | 28.57%18 | 0 | 42.31%37 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |